MARTIN VENTURA, JOSE LUIS
iMarina ID: 04-261698Códigos de identificación
Departamento Universitario
Medicina. Universidad Autónoma de Madrid. Ciudad Universitaria de Cantoblanco. Madrid. 28049
Centro
Facultad de Medicina. Universidad Autónoma de Madrid. Ciudad Universitaria de Cantoblanco. Madrid. 28049
Grupo
Laboratorio De Remodelado Vascular. Universidad Autónoma de Madrid. Ciudad Universitaria de Cantoblanco. Madrid. 28049
Área de Conocimiento
Medicina
Timeline
diciembre de 2003
Doctorado: DOCTOR/A
Universidad Autónoma de Madrid
enero de 2003
Doctorado: Doctor/a
Universidad Autónoma de Madrid
Reconocimientos Docentes
Quinquenios
2
Año último Quinquenio: 2018
Reconocimientos Investigación
Sexenios
3
Año último Sexenio: 2016
Timeline
diciembre de 2018
Coordinador/a
Universidad Autónoma de Madrid. Laboratorio De Remodelado Vascular
2018 -
noviembre de 2013
Profesor Contratado Doctor LOU
Universidad Autónoma de Madrid. Medicina
2013 -
diciembre de 2008
Ramón y Cajal. Medicina
Universidad Autónoma de Madrid
2008 - 2013
febrero de 2008
Titulado superior. Medicina
Universidad Autónoma de Madrid
2008 - 2008
Doctorado
Universidad Autónoma de Madrid
2003 -
Publicaciones en Altmetrics
| 2020 | Complement C5 Protein as a Marker of Subclinical Atherosclerosis | |
| 2020 | Macrophage cholesterol efflux downregulation is not associated with abdominal ao... | |
| 2019 | Pathophisiology of abdominal aortic aneurysm: biomarkers and novel therapeutic t... | |
| 2019 | A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty res... | |
| 2019 | Role of complement system in pathological remodeling of the vascular wall | |
| 2019 | APOA1 oxidation is associated to dysfunctional high-density lipoproteins in huma... | |
| 2018 | Combination of biomarkers of vascular calcification and sTWEAK to predict cardio... | |
| 2018 | Potential role of insulin receptor isoforms and IGF receptors in plaque instabil... | |
| 2018 | Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux i... | |
| 2018 | Lipocalin-2, a potential therapeutic target in advanced atherosclerosis | |
| 2018 | Arachidonic Acid, but Not Omega-3 Index, Relates to the Prevalence and Progressi... | |
| 2017 | Increased galectin-3 levels are associated with abdominal aortic aneurysm progre... | |
| 2017 | Oxidative stress in human atherothrombosis: Sources, markers and therapeutic tar... | |
| 2017 | Association of ficolin-3 with abdominal aortic aneurysm presence and progression | |
| 2017 | The Application of Proteomic Techniques in the Study of HDL Particle Characteriz... | |
| 2017 | TWEAK blockade decreases atherosclerotic lesion size and progression through sup... | |
| 2017 | Soluble TWEAK and atheromatosis progression in patients with chronic kidney dise... | |
| 2016 | Plasma levels of monocyte chemoattractant protein-1, n-terminal fragment of brai... | |
| 2016 | Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm de... | |
| 2016 | Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: ... | |
| 2016 | Vascular Proteomics | |
| 2016 | ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and ather... | |
| 2016 | Soluble TWEAK and major adverse cardiovascular events in patients with CKD | |
| 2016 | Parathormone levels are independently associated with the presence of left ventr... | |
| 2016 | A Single In-Vial Dual Extraction Strategy for the Simultaneous Lipidomics and Pr... | |
| 2016 | Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybr... | |
| 2016 | Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human A... | |
| 2016 | Down-regulation of Fibulin-5 is associated with aortic dilation: Role of inflamm... | |
| 2016 | Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm pro... | |
| 2015 | Biomarkers and predictive models for abdominal aortic aneurysm growth [Estudio d... | |
| 2015 | N-terminal pro-brain natriuretic peptide is associated with a future diagnosis o... | |
| 2015 | Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression ... | |
| 2015 | The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Dise... | |
| 2015 | Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 le... | |
| 2015 | Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abd... | |
| 2015 | Targeted gold-coated iron oxide nanoparticles for CD163 detection in atheroscler... | |
| 2015 | Differential profile in inflammatory and mineral metabolism biomarkers in patien... | |
| 2015 | TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activatio... | |
| 2015 | Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis facto... | |
| 2015 | Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in ... | |
| 2015 | Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH o... | |
| 2015 | ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm prog... | |
| 2014 | Tumor necrosis factor-like weak inducer of apoptosis or fn14 deficiency reduce e... | |
| 2014 | Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, a... | |
| 2014 | Assessment of Biomarkers and Predictive Model for Short-term Prospective Abdomin... | |
| 2014 | Label-free quantitative proteomic analysis of human plasma-derived microvesicles... | |
| 2014 | Pathology of human plaque vulnerability: Mechanisms and consequences of intrapla... | |
| 2014 | RNA binding protein HuR regulates the expression of ABCA1 | |
| 2014 | Galectin-3, a biomarker linking oxidative stress and inflammation with the clini... | |
| 2014 | Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosi... | |
| 2014 | Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce e... | |
| 2014 | From tissue iron retention to low systemic haemoglobin levels, new pathophysiolo... | |
| 2014 | Label-free proteomic analysis of red blood cell membrane fractions from abdomina... | |
| 2013 | Soluble TWEAK is associated with atherosclerotic burden in patients with chronic... | |
| 2013 | Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aorti... | |
| 2013 | Statin use in aortic aneurismal disease to prevent progression and cardiovascula... | |
| 2013 | Proteomic analysis of intraluminal thrombus highlights complement activation in ... | |
| 2013 | HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in ather... | |
| 2013 | Unraveling biomarkers of abdominal aortic aneurisms by iTRAQ analysis of deplete... | |
| 2013 | Identification of novel biomarkers of abdominal aortic aneurysms by 2D-DIGE and ... | |
| 2013 | HDL and endothelial protection | |
| 2012 | Erythrocytes, leukocytes and platelets as a source of oxidative stress in chroni... | |
| 2012 | HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosc... | |
| 2012 | Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic a... | |
| 2012 | Oxidative stress in cardiovascular pathologies: Genetics, cellular, and molecula... | |
| 2012 | From intraplaque haemorrhages to plaque vulnerability: Biological consequences o... | |
| 2012 | Cell stress proteins in atherothrombosis. | |
| 2012 | Increased plasma levels of NGAL, a marker of neutrophil activation, in patients ... | |
| 2012 | Plasma profiling by a protein array approach identifies IGFBP-1 as a novel bioma... | |
| 2012 | Metabolomic study of plasma of patients with abdominal aortic aneurysm | |
| 2011 | TWEAKFn14 interaction enhances plasminogen activator inhibitor 1 and tissue fact... | |
| 2011 | Metabolites secreted by human atherothrombotic aneurysms revealed through a meta... | |
| 2011 | Insulin-like growth factor i - A novel biomarker of abdominal aortic aneurysms | |
| 2011 | Diagnostic and therapeutic strategies for small abdominal aortic aneurysms | |
| 2011 | Induction of macrophage chemotaxis by aortic extracts from patients with marfan ... | |
| 2011 | CCL20 Is Increased in Hypercholesterolemic Subjects and Is Upregulated By LDL in... | |
| 2011 | Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans | |
| 2011 | Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a nov... | |
| 2011 | Animal Models of Cardiovascular Diseases | |
| 2011 | Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysm... | |
| 2011 | Vascular proteomics and the discovery process of clinical biomarkers: The case o... | |
| 2011 | Targeted and non-targeted metabolic time trajectory in plasma of patients after ... | |
| 2011 | Study of the capillary electrophoresis profile of intact α-1-acid glycoprotein i... | |
| 2011 | Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneur... | |
| 2011 | Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortal... | |
| 2010 | Combined therapy with renin-angiotensin system and calcium channel blockers in t... | |
| 2010 | Heat shock protein 90 inhibitors attenuate inflammatory responses in atheroscler... | |
| 2010 | Local Non-Esterified Fatty Acids Correlate With Inflammation in Atheroma Plaques... | |
| 2010 | TWEAK soluble, un nuevo biomarcador de riesgo cardiovascular | |
| 2010 | Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio | |
| 2010 | Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAA... | |
| 2010 | Proteomic strategies in the search of new biomarkers in atherothrombosis | |
| 2010 | Proteomic and metabolomic profiles in atherothrombotic vascular disease | |
| 2009 | Plasma fingerprinting with GC-MS in acute coronary syndrome | |
| 2009 | HDL antielastase activity prevents smooth muscle cell anoikis, a potential new a... | |
| 2009 | Cardiovascular Risk and Antiangiogenic Therapy for Age-related Macular Degenerat... | |
| 2009 | The MIF Receptor CD74 in Diabetic Podocyte Injury | |
| 2009 | Search for Serum Biomarkers Associated with Abdominal Aortic Aneurysm Growth - A... | |
| 2009 | Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 a... | |
| 2009 | The proteomic approach in the development of prognostic biomarkers in atherothro... | |
| 2009 | Biomarkers in Cardiovascular Medicine | |
| 2009 | Las proteínas de choque térmico (heat shock proteins) como potenciales dianas te... | |
| 2009 | Respuesta | |
| 2009 | Increased CD74 expression in human atherosclerotic plaques: contribution to infl... | |
| 2009 | New mediators implicated in atherogenesis | |
| 2009 | Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses Duri... | |
| 2009 | Soluble TWEAK plasma levels as a novel biomarker of endothelial function in pati... | |
| 2009 | The CD163-expressing macrophages recognize and internalize TWEAK. Potential cons... | |
| 2009 | Vascular proteomics, a translational approach: From traditional to novel proteom... | |
| 2009 | Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular a... | |
| 2009 | Improving metabolite knowledge in stable atherosclerosis patients by association... | |
| 2009 | Considering TWEAK as a target for therapy in renal and vascular injury | |
| 2009 | Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis ... | |
| 2008 | Plasma concentration of heat shock protein 27 and risk of cardiovascular disease... | |
| 2008 | Adiponectin plasma levels are increased by atorvastatin treatment in subjects at... | |
| 2008 | Proteomics in atherosclerosis | |
| 2008 | Effect of Intensive Atorvastatin Therapy on Prostaglandin E2 Levels and Metallop... | |
| 2008 | Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular... | |
| 2008 | Treatment with amlodipine and atorvastatin has additive effect on blood and plaq... | |
| 2008 | LDL induces parathyroid hormone-related protein expression in vascular smooth mu... | |
| 2008 | Soluble Fas ligand plasma levels are associated with forearm reactive hyperemia ... | |
| 2007 | Characterization of the human atheroma plaque secretome by proteomic analysis | |
| 2007 | TWEAK and Fn14. New players in the pathogenesis of atherosclerosis | |
| 2007 | Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (... | |
| 2007 | TRAIL and vascular injury | |
| 2007 | Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activat... | |
| 2007 | Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk ... | |
| 2007 | Pleiotropic effects of telmisartan in diabetic patients | |
| 2007 | Mechanisms of action of statins in stroke | |
| 2007 | Low plasma levels of HSP70 in patients with carotid atherosclerosis are associat... | |
| 2007 | Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Ato... | |
| 2007 | Proteomics in atherothrombosis: a future perspective | |
| 2007 | Etanol beverages containing polyphenols decrease nuclear factor kappa-B activati... | |
| 2007 | Atorvastatin modulates the profile of proteins released by human atherosclerotic... | |
| 2006 | Losartan improves resistance artery lesions and prevents CTGF and TGF-beta produ... | |
| 2006 | Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is e... | |
| 2006 | Atorvastatin reduces the expression of prostaglandin E2 receptors in human carot... | |
| 2006 | Retention and Activation of Blood-Borne Proteases in the Arterial Wall. Implicat... | |
| 2006 | Plasminogen activation: A mediator of vascular smooth muscle cell apoptosis in a... | |
| 2006 | Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptor... | |
| 2006 | Biological significance of decreased HSP27 in human atherosclerosis | |
| 2006 | Biology of atherosclerotic plaques: What we are learning from proteomic analysis | |
| 2006 | Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive pa... | |
| 2005 | HMG-CoA reductase inhibitors reduce IκB kinase activity induced by oxidative str... | |
| 2005 | Quest for novel cardiovascular biomarkers by proteomic analysis | |
| 2005 | Inflammatory biomarkers and statins | |
| 2005 | Proteomic approach in the search of new cardiovascular biomarkers | |
| 2005 | Intensive treatment with atorvastatin reduces inflammation in mononuclear cells ... | |
| 2004 | Intensive treatment with statins and the progression of cardiovascular diseases:... | |
| 2004 | Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear... | |
| 2004 | NF-κB Activation and Fas Ligand Overexpression in Blood and Plaques of Patients ... | |
| 2004 | Statins in hypertensive patients: Potential explanations for the ASCOT-LLA study... | |
| 2004 | Identification by a differential proteomic approach of heat shock protein 27 as ... | |
| 2004 | Decreased circulating Fas ligand in patients with familial combined hyperlipidem... | |
| 2003 | Anti-inflammatory and immunomodulatory effects of statins | |
| 2003 | Proteomic analysis of human vessels: Application to atherosclerotic plaques | |
| 2003 | Simvastatin reduces NF-kappa B activity in peripheral mononuclear and in plaque ... | |
| 2003 | 3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibitors decrease Fas ligand e... | |
| 2003 | Possible role of parathyroid hormone-related protein as a proinflammatory cytoki... | |
| 2003 | Atorvastatin diminishes Fas ligand expression in atherosclerotic plaques and blo... | |
| 2002 | Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of ath... |
Temáticas más frecuentes
Temáticas
Proyectos participados
Dirección y participación en proyectos
IP
NO IP
Grupos, Redes
Laboratorio De Remodelado Vascular
Asignatura / Curso
Actividad docente
Tesis Dirigidas
7
Centros
Universidad Autónoma de Madrid
Colaboración institucional últimos 5 años
